Interní Med. 2019; 21(4): 223-227 | DOI: 10.36290/int.2019.034

Specifics of diabetes in old age

MUDr. Markéta Kubíčková
III. interní gerontometabolická klinika, Fakultní nemocnice Hradec Králové

Diabetes mellitus (DM) is a major global problem, especially as its incidence continues to increase. This is due both to the increasing life expectancy and also to the prevailing lifestyle, which is characterized by low physical activity and high-energy diets. Currently, there are over 900,000 patients with diabetes in the Czech Republic, and more than one third of these patients are in the geriatric category (1). The incidence of diabetic complications is also increasing. These are, on one hand, microvascular changes specific to diabetes mellitus (retino, neuro, nephropathy), on the other hand, diabetics are more at risk of cardiovascular diseases (ischemic heart disease, atherosclerosis of extremity arteries and cerebral vascular disease), heart failure and sudden cardiac death (2, 3, 4). In addition, often present cognitive disorders and depression complicate the situation (5, 6). In addition, memory loss and visual impairment worsen the results of DM treatment. Generally, there are two categories of geriatric patients, namely patients who are proficient, without severe comorbidities, and those who are fragile, with a significant reduction in self-sufficiency. The treatment of these two groups of patients is fundamentally different (9). While proficient patients can be treated in the same way as younger and middle-aged patients, fragile patients require a highly individualized approach favoring in particular the safety of treatment with looser goals (7, 8).

Keywords: diabetes mellitus, geriatrics, complications, frailty, treatment goal

Published: November 1, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kubíčková M. Specifics of diabetes in old age. Interní Med. 2019;21(4):223-227. doi: 10.36290/int.2019.034.
Download citation

References

  1. Svačina Š, Jurašková B, Karen I. Diabetes mellitus. Léčba u starších pacientů v ČR. Doporučené diagnostické a terapeutické postupy pro všeobecné praktické lékaře. Centrum doporučených postupů pro praktické lékaře. Společnost všeobecného lékařství, Praha 2014, novelizace 2019
  2. Kirkman MS, Briscoe VJ, Clark N, et al. Diabetes in older adults : a consensus report. J Am Geriatr Soc 2012: 60: 2342 Go to original source... Go to PubMed...
  3. Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes. 2008; 26: 77-82. Go to original source...
  4. Heydari I, Radi V, Razmjou S, Amiri A. Chronic complications of diabetes mellitus in newly diagnosed patients. Int J Diabetes Mellitus. 2010; 2: 61-63. Go to original source...
  5. Whitmer RA, Karter AJ, Yaffe K, et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA. 2009;301(15):1565 Go to original source... Go to PubMed...
  6. Yaffe K, Falvey CM, Hamilton N, et al. Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern Med 2013; 173: 1300. Go to original source... Go to PubMed...
  7. American Diabetes Association. 11. Older Adults: Standards of Medical Care in Diabetes-2018. Diabetes Care 2018; 41: S119. Go to original source... Go to PubMed...
  8. International Diabetes Federation. Managing older people with type 2 diabetes, Global Guideline https://www.idf.org/sites/default/files/IDF%20Guideline%20for%20Older%20People.pdf (Accessed on February 24, 2014).
  9. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2015; 58:429. Go to original source... Go to PubMed...
  10. American Diabetes Association, Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018,Diabetes Care 2018 Jan; 41(Supplement 1): S13-27. Go to original source... Go to PubMed...
  11. ADA. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008;31(Suppl 1): S62-67. Go to original source... Go to PubMed...
  12. http://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2013.pdf.
  13. Zdravotnictví ČR:Stručný přehled činnosti oboru diabetologie a endokrinologie za období 2007-2016. https://www.uzis.cz
  14. Wannamethee SG, Welsh P, Papacosta O, Lennon L, Whincup PH, Sattar N. Copeptin, insulin resistance and risk of incident diabetes in older men. J Clin Endocrinol Metab. 2015; 100: 3332-3339. Go to original source... Go to PubMed...
  15. Enhörning S, Struck J, Wirfält E, Hedblad B, Morgenthaler NG, Melander O. Plasma copeptin, a unifying factor behind the metabolic syndrome. J Clin Endocrinol Metab. 2011;96: E1065-1072. Go to original source... Go to PubMed...
  16. Sung CC, Liao MT, Lu KC, Wu CC. Role of vitamin D in insulin resistance. J Biomed Biotechnol. 2012; 2012: 634195 Go to original source... Go to PubMed...
  17. Li YX, Zhou L. Vitamin D deficiency, obesity and diabetes. Cell Mol Biol (Noisy-le-grand) 2015; 61: 35-38.
  18. Cândido FG, Bressan J. Vitamin D: Link between osteoporosis, obesity, and diabetes? Int J Mol Sci. 2014; 15: 6569-6591. Go to original source... Go to PubMed...
  19. Chaudhary DP, Sharma R, Bansal DD. Implications of magnesium deficiency in type 2 diabetes: A review. Biol Trace Elem Res. 2010; 134: 119-129. Go to original source... Go to PubMed...
  20. Dasgupta A, Sarma D, Saikia UK. Hypomagnesemia in type 2 diabetes mellitus. Indian J Endocrinol Metab. 2012; 16: 1000-1003. Go to original source... Go to PubMed...
  21. Chau D, Edelman SV. Clinical management of diabetes in the elderly. Clin Diabetes. 2001; 19: 172-175. Go to original source...
  22. Chen ST, Siddarth P, Ercoli LM, Merrill DA, Torres-Gil F, Small GW. Modifiable risk factors for Alzheimer disease and subjective memory impairment across age groups. PLoS One. 2014; 9: e98630. Go to original source... Go to PubMed...
  23. Altabas V. Diabetes, endothelial dysfunction, and vascular repair: What should a diabetologist keep his eye on? Int J Endocrinol. 2015; 2015: 848272. Go to original source... Go to PubMed...
  24. Becker C, Schneider C, Aballéa S,et al. Cataract in patients with diabetes mellitus - incidence rates in UK and risk factors. Eye (Lond)2018: 32: 1028 Go to original source... Go to PubMed...
  25. Horwitz A, Petrovski BÉ, Torp-Pedersen C, Kolko M. Danish Nationwide Data Reveal a Link between Diabetes Mellitus, Diabetic Retinopathy, and Glaucoma. J Diabetes Res 2016; 2016: 2684674. Go to original source... Go to PubMed...
  26. Wing RR, Hamman RF, Bray GA, et al. Achieving weight and activity goals among diabetes prevention program lifestyle participants. Obes Res 2004; 12: 1426. Go to original source... Go to PubMed...
  27. Christmas C, Andersen RA. Exercise and older patients: guidelines for the clinician. J Am Geriatr Soc 2000; 48: 318. Go to original source... Go to PubMed...
  28. Karani R, McLaughlin MA, Cassel CK. Exercise in the healthy older adult. Am J Geriatr Cardiol 2001; 10: 269. Go to original source... Go to PubMed...
  29. Morey MC, Pieper CF, Crowley GM, et al. Exercise adherence and 10-year mortality in chronically ill older adults. J Am Geriatr Soc 2002; 50: 1929. Go to original source... Go to PubMed...
  30. Heath JM, Stuart MR. Prescribing exercise for frail elders. J Am Board Fam Pract 2002; 15: 218. Go to PubMed...
  31. Fiatarone MA, O'Neill EF, Ryan ND, et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med 1994; 330: 1769. Go to original source... Go to PubMed...
  32. Miller CK, Edwards L, Kissling G, Sanville L. Nutrition education improves metabolic outcomes among older adults with diabetes mellitus: results from a randomized controlled trial. Prev Med. 2002; 34(2): 252. Go to original source... Go to PubMed...
  33. Kim MJ, Han JY, Shin JY, Kim SI, Lee JM, Hong S, et al. Metformin-associated lactic acidosis: Predisposing factors and outcome. Endocrinol Metab (Seoul) 2015; 30: 78-83. Go to original source... Go to PubMed...
  34. Bell DS. Metformin-induced vitamin B12 deficiency presenting as a peripheral neuropathy. South Med J. 2010; 103: 265-267. Go to original source... Go to PubMed...
  35. Goodarzi, M.O., Bryer-Ash, M. Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents. Diabetes Obes Metab. 2005; 7: 654-665 Go to original source... Go to PubMed...
  36. Bailey, C.J., Turner, R.C. Metformin. N Engl J Med. 1996; 334: 574-579 Go to original source... Go to PubMed...
  37. Mannucci, E., Ognibene, A., Cremasco, F., Bardini, G., Mencucci, A., Pierazzuoli, E. et al, Effect of metformin on glucagon - like peptide 1 (GLP-1) and leptin levels in obese nondiabetic subjects. Diabetes Care. 2001; 24: 489-449 Go to original source... Go to PubMed...
  38. Halimi S, Raccah D, Schweizer A, Dejager S. Role of vildagliptin in managing type 2 diabetes mellitus in the elderly. Curr Med Res Opin. 2010; 26: 1647-1656. Go to original source... Go to PubMed...
  39. Bode BW, Brett J, Falahati A, Pratley RE. Comparison of the efficacy and tolerability profile of liraglutide, a once-daily human GLP-1 analog, in patients with type 2 diabetes>=65 and<65 years of age: A pooled analysis from phase III studies. Am J Geriatr Pharmacother. 2011; 9: 423-433 Go to original source... Go to PubMed...
  40. Yabe D, Nishikino R, Kaneko M, Iwasaki M, Seino Y. Short-term impacts of sodium/glucose co-transporter 2 inhibitors in Japanese clinical practice: Considerations for their appropriate use to avoid serious adverse events. Expert Opin Drug Saf. 2015; 14: 795-800 Go to original source... Go to PubMed...
  41. Mikhail N. Place of sodium-glucose co-transporter type 2 inhibitors for treatment of type 2 diabetes. World J Diabetes. 2014; 5: 854-859. Go to original source... Go to PubMed...
  42. Duarte AI, Candeias E, Correia SC, Santos RX, Carvalho C, Cardoso S, et al. Crosstalk between diabetes and brain: Glucagon - like peptide-1 mimetics as a promising therapy against neurodegeneration. Biochim Biophys Acta. 2013; 1832: 527-541 Go to original source... Go to PubMed...
  43. Benroubi M. Fear, guilt feelings and misconceptions: Barriers to effective insulin treatment in type 2 diabetes. Diabetes Res Clin Pract. 2011;93(Suppl 1): S97-99. Go to original source... Go to PubMed...
  44. Munshi MN, Slyne C, Segal AR, et al. Simplification of Insulin Regimen in Older Adults and Risk of Hypoglycemia. JAMA Intern Med 2016; 176: 1023. Go to original source... Go to PubMed...
  45. Schopman JE, Simon AC, Hoefnagel SJ, et al. The incidence of mild and severe hypoglycaemia in patients with type 2 diabetes mellitus treated with sulfonylureas: a systematic review and meta-analysis. Diabetes Metab Res Rev 2014; 30: 11. Go to original source... Go to PubMed...
  46. Lipska KJ, Ross JS, Wang Y, et al. National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011. JAMA Intern Med 2014; 174: 1116. Go to original source... Go to PubMed...
  47. Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011; 365:2002. Go to original source... Go to PubMed...
  48. Shorr RI, Ray WA, Daugherty JR, Griffin MR. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med 1997; 157: 1681. Go to original source...
  49. Papa G, Fedele V, Rizzo MR, et al. Safety of type 2 diabetes treatment with repaglinide compared with glibenclamide in elderly people: A randomized, open-label, two-period, cross-over trial. Diabetes Care 2006; 29: 1918. Go to original source... Go to PubMed...
  50. Ligthelm RJ, Kaiser M, Vora J, Yale JF. Insulin use in elderly adults: risk of hypoglycemia and strategies for care. J Am Geriatr Soc 2012; 60: 1564. Go to original source... Go to PubMed...
  51. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2015; 58: 429. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.